<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Takahara K</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>The goal of schwannoma resection is to control the tumor while preserving neurological function. Schwannomas have a variable postoperative growth pattern, therefore preoperative prediction of a schwannoma's growth pattern is favorable. This study aimed to examine the relationship between preoperative neutrophil-to-lymphocyte ratio (NLR) and postoperative recurrence and retreatment in patients with schwannoma.&lt;h4>Methods&lt;/h4>We retrospectively examined 124 patients who underwent schwannoma resection in our institution. Associations between preoperative NLR, other patient and tumor characteristics, and tumor recurrence and retreatment were analyzed.&lt;h4>Results&lt;/h4>Median follow-up was 2569.5 days. Postoperative recurrence occurred in 37 patients. Recurrence that required retreatment occurred in 22. Treatment-free survival (TFS) was significantly shorter in patients with NLR ≥2.21 (&lt;i>P&lt;/i> = 0.0010). Multivariate Cox proportional hazards regression showed that NLR and neurofibromatosis type 2 were independent predictors of retreatment (&lt;i>P&lt;/i> = 0.0423 and 0.0043, respectively). TFS was significantly shorter in patients with NLR ≥2.21 in the following subgroups: sporadic schwannoma, primary schwannoma, schwannoma ≥30 mm in size, subtotal resection, vestibular schwannoma, and postoperative recurrence.&lt;h4>Conclusions&lt;/h4>Preoperative NLR ≥2.21 before surgery was significantly associated with retreatment after schwannoma resection. NLR may be a novel predictor of retreatment and assist surgeons in preoperative surgical decision making.</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>1099384</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9950385</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in surgically resected schwannomas.</pubmed_title><pmcid>PMC9950385</pmcid><pubmed_authors>Kuranari Y</pubmed_authors><pubmed_authors>Takahara K</pubmed_authors><pubmed_authors>Tamura R</pubmed_authors><pubmed_authors>Toda M</pubmed_authors><pubmed_authors>Karatsu K</pubmed_authors><pubmed_authors>Akiyama T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in surgically resected schwannomas.</name><description>&lt;h4>Objective&lt;/h4>The goal of schwannoma resection is to control the tumor while preserving neurological function. Schwannomas have a variable postoperative growth pattern, therefore preoperative prediction of a schwannoma's growth pattern is favorable. This study aimed to examine the relationship between preoperative neutrophil-to-lymphocyte ratio (NLR) and postoperative recurrence and retreatment in patients with schwannoma.&lt;h4>Methods&lt;/h4>We retrospectively examined 124 patients who underwent schwannoma resection in our institution. Associations between preoperative NLR, other patient and tumor characteristics, and tumor recurrence and retreatment were analyzed.&lt;h4>Results&lt;/h4>Median follow-up was 2569.5 days. Postoperative recurrence occurred in 37 patients. Recurrence that required retreatment occurred in 22. Treatment-free survival (TFS) was significantly shorter in patients with NLR ≥2.21 (&lt;i>P&lt;/i> = 0.0010). Multivariate Cox proportional hazards regression showed that NLR and neurofibromatosis type 2 were independent predictors of retreatment (&lt;i>P&lt;/i> = 0.0423 and 0.0043, respectively). TFS was significantly shorter in patients with NLR ≥2.21 in the following subgroups: sporadic schwannoma, primary schwannoma, schwannoma ≥30 mm in size, subtotal resection, vestibular schwannoma, and postoperative recurrence.&lt;h4>Conclusions&lt;/h4>Preoperative NLR ≥2.21 before surgery was significantly associated with retreatment after schwannoma resection. NLR may be a novel predictor of retreatment and assist surgeons in preoperative surgical decision making.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-05T13:20:49.866Z</modification><creation>2025-04-05T13:20:49.866Z</creation></dates><accession>S-EPMC9950385</accession><cross_references><pubmed>36845735</pubmed><doi>10.3389/fonc.2023.1099384</doi></cross_references></HashMap>